Entry Rationale
Noting the news of strong Q2 performance, we decided to enter based on the additional upside potential as the current price is above the 20‑day resistance level of $4.43.
Kopin stock rises 25% after Q2 revenue beats estimates
Kopin's Q2 revenue exceeded market expectations, and the stock price rose 25%.
Noting the news of strong Q2 performance, we decided to enter based on the additional upside potential as the current price is above the 20‑day resistance level of $4.43.
If the upward momentum from strong Q2 performance continues and the price reaches the 20‑day resistance level around $4.43, I would consider taking profit; if the price declines and breaks below the support level at $3.15, I would manage risk by cutting loss.
The 14‑day RSI is 57.9, indicating a neutral level; the moving averages are in a non‑aligned state; trading volume is 0.66 times the 20‑day average, somewhat low; and the price change over the past 7 days is +35.1%.
Based on strong Q2 revenue, a 25% surge news, and a recent 7‑day volatility of +35.1%, we set an expected return of 2.5% anticipating further upside, but the actual result recorded a -14.6% FAILED(손절선 도달 실패). Although at entry the 20‑day moving average was misaligned and volume was 0.66× the 20‑day average—somewhat weak—we overly focused on the superficial indicators of short‑term rally momentum and a break above the resistance level ($4.43), which analysis shows was the main cause of the failure to defend against the downside.
Through this review, I realized that rather than being misled by simple positive news and short‑term volatility (+35.1%), conservative risk management should be the top priority in periods where the trend foundation is unstable, such as when moving averages are not aligned. Going forward, I will reflect actionable adjustments in trading, such as reducing position size or applying stricter stop‑loss criteria for stocks that lack accompanying volume or have misaligned moving averages.